175 related articles for article (PubMed ID: 16489362)
1. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Imran H; Tleyjeh IM; Zirakzadeh A; Rodriguez V; Khan SP
Bone Marrow Transplant; 2006 Apr; 37(7):677-86. PubMed ID: 16489362
[TBL] [Abstract][Full Text] [Related]
2. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review.
Zhang L; Wang Y; Huang H
Clin Transplant; 2012; 26(4):511-9. PubMed ID: 22428954
[TBL] [Abstract][Full Text] [Related]
3. Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Gökce M; Kuskonmaz B; Cetin M; Uckan Cetinkaya D; Tuncer M
Exp Clin Transplant; 2013 Oct; 11(5):440-6. PubMed ID: 24128137
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
Tay J; Tinmouth A; Fergusson D; Huebsch L; Allan DS
Biol Blood Marrow Transplant; 2007 Feb; 13(2):206-17. PubMed ID: 17241926
[TBL] [Abstract][Full Text] [Related]
5. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
6. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature.
Hopps SA; Borders EB; Hagemann TM
J Oncol Pharm Pract; 2016 Jun; 22(3):496-510. PubMed ID: 26126501
[TBL] [Abstract][Full Text] [Related]
10. Hepatic veno-occlusive disease.
Ribaud P; Gluckman E
Pediatr Transplant; 1999; 3 Suppl 1():41-4. PubMed ID: 10587970
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
12. Venous occlusive disease in children.
Gharib MI; Bulley SR; Doyle JJ; Wynn RF
Thromb Res; 2006; 118(1):27-38. PubMed ID: 16154622
[No Abstract] [Full Text] [Related]
13. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Hassan Z
Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
[No Abstract] [Full Text] [Related]
14. Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
Lakshminarayanan S; Sahdev I; Goyal M; Vlachos A; Atlas M; Lipton JM
Pediatr Transplant; 2010 Aug; 14(5):618-21. PubMed ID: 20051023
[TBL] [Abstract][Full Text] [Related]
15. [Combine low-dose heparin with prostaglandin E1 and Dextran 40 to prevent and treat hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Li QP; Zhu WG; Yin XJ; Feng ZC
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):537-8. PubMed ID: 15324577
[No Abstract] [Full Text] [Related]
16. Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Ahn H; Tay J; Shea B; Hutton B; Shorr R; Knoll GA; Cameron DW; Cowan J
Transfusion; 2018 Oct; 58(10):2437-2452. PubMed ID: 29770447
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH; Giralt SA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
[TBL] [Abstract][Full Text] [Related]
18. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.
Kumar S; DeLeve LD; Kamath PS; Tefferi A
Mayo Clin Proc; 2003 May; 78(5):589-98. PubMed ID: 12744547
[TBL] [Abstract][Full Text] [Related]
19. [Veno-occlusive disease--an important complication in hematopoietic cells transplantation].
Skotnicki AB; Krawczyk J
Przegl Lek; 2001; 58(11):995-9. PubMed ID: 11987843
[TBL] [Abstract][Full Text] [Related]
20. [A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Qin CJ; Liu LJ; Zhang ZM; Luo L; Lai YR; Li QC
Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):483-486. PubMed ID: 29996265
[No Abstract] [Full Text] [Related]
[Next] [New Search]